Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience

The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes

(2018) D. A. Axelrod et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients

(2018) Matthew Kadatz et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients

(2018) Christine M. Durand et al.   ANNALS OF INTERNAL MEDICINE

The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States

(2018) Christine M. Durand et al.   ANNALS OF INTERNAL MEDICINE

Achieving Sustained Virologic Response in Liver Transplant Recipients with Hepatitis C Decreases Risk of Decline in Renal Function

(2018) Sanjaya K. Satapathy et al.   LIVER TRANSPLANTATION

Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients

(2018) M. Bodro et al.   TRANSPLANTATION PROCEEDINGS

Cost-effectiveness of hepatitis C-positive donor kidney transplantation for hepatitis C-negative recipients with concomitant direct-acting antiviral therapy

(2018) Gaurav Gupta et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients

(2018) Peter P. Reese et al.   ANNALS OF INTERNAL MEDICINE

Use of hepatitis C viraemic organs in kidney transplantation: a need to hit the pause button?

(2018) Allison J. Kwong et al.   Nature Reviews Gastroenterology & Hepatology

Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients

(2017) David S. Goldberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C

(2016) Sarah Talavera Pons et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans

(2015) Miklos Z. Molnar et al.   HEPATOLOGY

Transplanting Hepatitis C–Positive Kidneys

(2015) Peter P. Reese et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

(2015) Graham R. Foster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Innate immune cell networking in hepatitis C virus infection

(2014) Banishree Saha et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mixed genotype hepatitis C infections and implications for treatment

(2013) Anna L. McNaughton et al.   HEPATOLOGY

Experience of Fibrosing Cholestatic Hepatitis With Hepatitis C Virus in Kidney Transplant Recipients

(2012) A.R. Siddiqui et al.   TRANSPLANTATION PROCEEDINGS

Underutilization of Hepatitis C-Positive Kidneys for Hepatitis C-Positive Recipients

(2010) L. M. Kucirka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Frequent multiple hepatitis C virus infections among injection drug users in a prison setting

(2010) Son T. Pham et al.   HEPATOLOGY

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

(2008) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS